Bristol-Myers Squibb Co’s filing revealed that its President, RayzeBio Org. Hickey Benjamin unloaded Company’s shares for reported $3702.0 on May 09 ’25. In the deal valued at $38.01 per share,97 shares were sold. As a result of this transaction, Hickey Benjamin now holds 0 shares worth roughly $0.0.
Then, Hirawat Samit bought 4,250 shares, generating $202,215 in total proceeds. Upon buying the shares at $47.58, the EVP,Chief Med.Offr.,Drug Dev. now owns 83,513 shares.
Before that, BOERNER CHRISTOPHER S. bought 2,000 shares. Bristol-Myers Squibb Co shares valued at $110,096 were divested by the Chief Executive Officer at a price of $55.05 per share. As a result of the transaction, BOERNER CHRISTOPHER S. now holds 104,626 shares, worth roughly $5.21 million.
Piper Sandler initiated its Bristol-Myers Squibb Co [BMY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. Jefferies also remained covering BMY and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of BMY
On Friday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock fall -1.85% to $49.75. Over the last five days, the stock has gained 2.77%. Bristol-Myers Squibb Co shares have fallen nearly -12.04% since the year began. Nevertheless, the stocks have risen 15.64% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $39.35 was recorded on 05/14/25.
Levels Of Support And Resistance For BMY Stock
The 24-hour chart illustrates a support level at 49.45, which if violated will result in even more drops to 49.14. On the upside, there is a resistance level at 50.26. A further resistance level may holdings at 50.76.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-05-30, dropping by -4.58 million shares to a total of 32.54 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 37.12 million shares. There was a decline of -14.07%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 15, 2024 when Wolfe Research began covering the stock and recommended ‘”a Peer perform”‘ rating .
